Overview
Kojiro Otsuka practices in Kobe, Japan. Mr. Otsuka is rated as an Advanced expert by MediFind in the treatment of Asthma. His top areas of expertise are Pneumonia, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Lung Cancer.
His clinical research consists of co-authoring 67 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Asthma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Interstitial PneumoniaMr. Otsuka isAdvanced. Learn about Acute Interstitial Pneumonia.
- AsthmaMr. Otsuka isAdvanced. Learn about Asthma.
- Congenital Bronchobiliary FistulaMr. Otsuka isAdvanced. Learn about Congenital Bronchobiliary Fistula.
- EGFR Positive Lung CancerMr. Otsuka isAdvanced. Learn about EGFR Positive Lung Cancer.
- Interstitial Lung DiseaseMr. Otsuka isAdvanced. Learn about Interstitial Lung Disease.
- Lung CancerMr. Otsuka isAdvanced. Learn about Lung Cancer.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- Cardiac TamponadeMr. Otsuka isExperienced. Learn about Cardiac Tamponade.
- Chronic CoughMr. Otsuka isExperienced. Learn about Chronic Cough.
- Chronic Eosinophilic PneumoniaMr. Otsuka isExperienced. Learn about Chronic Eosinophilic Pneumonia.
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19Mr. Otsuka isExperienced. Learn about COVID-19.